← Browse by Condition
Medical Condition
ewing sarcoma
Total Trials
8
Recruiting Now
8
Trial Phases
Phase 1, Phase 1, Phase 2, Phase 2
ClinicalMetric tracks all active clinical trials for ewing sarcoma sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — ewing sarcoma Clinical Trials
How many clinical trials are currently recruiting for ewing sarcoma?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for ewing sarcoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for ewing sarcoma?
ewing sarcoma research spans Phase 1 (4 trials), Phase 2 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a ewing sarcoma clinical trial?
Eligibility criteria for ewing sarcoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 4
Phase 2 2
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06029218
Recruiting
Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy
Enrollment
106 pts
Location
France
Sponsor
Centre Antoine Lacassagne
NCT04995003 Phase 1
Recruiting
HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
Enrollment
25 pts
Location
United States
Sponsor
Baylor College of Medicine
NCT06926283 Phase 1
Recruiting
A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors
Enrollment
110 pts
Location
China
Sponsor
Hangzhou DAC Biotechnology Co....
NCT04308330 Phase 1
Recruiting
Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies
Enrollment
30 pts
Location
United States
Sponsor
New York Medical College
NCT06395103 Phase 1, Phase 2
Recruiting
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Enrollment
90 pts
Location
United States, Austr...
Sponsor
Merck Sharp & Dohme LLC
NCT06564272 Phase 2
Recruiting
A Study of KC1036 in Adolescents With Advanced Ewing Sarcoma
Enrollment
30 pts
Location
China
Sponsor
Beijing Konruns Pharmaceutical...
NCT05779670
Recruiting
Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage Surgery
Enrollment
50 pts
Location
Italy
Sponsor
Istituto Ortopedico Rizzoli
NCT05062707
Recruiting
Early Ageing During Therapy in AYA Cancer Patients
Enrollment
120 pts
Location
Netherlands
Sponsor
University Medical Center Gron...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology